Brain cancer device study for newly diagnosed high-grade glioma
Part of Cancer clinical trials.
This trial tests a medical device placed during brain surgery to trap tumor cells and make radiation therapy more effective. It is for people with suspected high-grade glioma who are scheduled for surgery and can receive standard treatment afterward.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 69 years
- Suspected new, single high-grade glioma seen on MRI
- Tumor is in the upper part of the brain, smaller than 60 cm³, and at least 90% can be safely removed
- You are healthy enough for daily activities (ECOG score 0–2)
- Able to have an MRI with contrast dye
- Willing to use effective birth control if you or your partner could become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a two-step treatment for newly diagnosed high-grade glioma: first laser treatment (LITT) to target the tumor, followed by a shorter, more focused course of radiation. It may help shrink or control the tumor while limiting treatment time.
This early-stage study measures electrical brain activity during brain tumor surgery to see if it can predict tumor return or progression. You may be offered the additional measurements while your surgeon removes a suspected or known high-grade glioma.
This early-phase trial tests a tiny implanted device placed during brain tumor surgery. It delivers very small doses of medicine directly to the tumor area for a short time, aiming to see if this approach is safe and workable in patients with certain gliomas.
This Phase 1 study tests a new brain-tumor treatment in people with recurrent (coming back) high-grade glioma (brain cancer). The study uses injected medicine along with an implanted tumor device and aims to find whether the treatment is safe and can shrink or control tumors.
This trial tests a special fluorescent dye (FG001) that helps surgeons see and remove high-grade brain tumors more completely during surgery. The dye is injected before surgery and glows under special light, potentially helping surgeons remove more tumor tissue safely.
This early-phase study tests a type of very targeted radiation given before surgery for people with a high-grade (aggressive) brain tumor. The goal is to see if this approach is safe and potentially improves treatment, while collecting tumor and blood samples for research.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.